Fundz

Next Rna Therapeutics, Inc. reported raising $23.4 Million in an initial SEC Form D filing, from an offering of $50 Million

PRIVATEJan 27, 2022$23.4M of $50M raised

Amount Raised

$23.4 Million

$23.4 Million sold, per SEC Form D (first sale Jan 27, 2022)

Round Type

Venture

BostonBiotechnology

Quick answer

NextRNA Therapeutics raised $23.4 Million in a funding round, dated January 27, 2022. NextRNA Therapeutics is based in Boston, Massachusetts, United States.

How much did NextRNA Therapeutics raise?
NextRNA Therapeutics raised $23.4 Million in a funding round on January 27, 2022.
What does NextRNA Therapeutics do?
NextRNA Therapeutics, Inc. is a Boston-based biotechnology company leading the next revolution of RNA-directed therapeutics.
Where is NextRNA Therapeutics based and how big is it?
NextRNA Therapeutics is based in Boston, Massachusetts, United States.
Who are the decision-makers at NextRNA Therapeutics?
Fundz holds 1 contact at NextRNA Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as NextRNA Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Satellite Biosciences, Inc. raised $82M on March 11, 2022.
  • BCD Bioscience, Inc. raised $12M on March 11, 2022.
  • RIGImmune raised $5K (Pre-Seed) on March 11, 2022.
  • NOULA HEALTH CO. raised $1.1M (Seed) on March 10, 2022.
  • GelMEDIX raised an undisclosed amount on March 10, 2022.
  • Nabgen, Inc. raised $100K (Pre-Seed) on March 10, 2022.

Who to call at NextRNA Therapeutics, and when

A new round usually means NextRNA Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NextRNA Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NextRNA Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at NextRNA Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NextRNA Therapeutics

Location

40 Guest St.

Boston, Massachusetts, United States

About

NextRNA Therapeutics, Inc. is a Boston-based biotechnology company leading the next revolution of RNA-directed therapeutics. Our focus is on identifying and drugging long non-coding RNAs (lncRNAs) with small molecules in oncology and neuroscience. Our proprietary computational engine, combined with deep lncRNA biology expertise and strong drug discovery capabilities, positions us well to unlock the therapeutic value of lncRNAs, a vast and promising target space. NextRNA has assembled an experienced team of industry leaders, biology and chemistry experts, and drug developers, all driven by a common passion for working together and having an impact on science and patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NextRNA Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for NextRNA Therapeutics's next move

See what Strategic adds

NextRNA Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.